- Fee assured
- Verified this account
- Skin cancer
Dr Cheung is a UK trained Consultant Dermatologist with a specialist interest in skin cancer and skin surgery. He is also experienced in managing a broad range of skin conditions such as acne, eczema, psoriasis, urticaria, skin allergies, axillary (armpit) excessive sweating with botulinum toxin injections and Roaccutane for severe acne. Also he is able to remove lumps and bumps from the skin such as warts, cysts and skin tags. Furthermore, he has experience in seeing patients with hair and nail problems.
He graduated from Dundee Medical School in 2000 where he obtained an additional medical science degree in Pharmacology with Honours. He finished his general medical training in Birmingham. His Dermatology specialist training was undertaken in the West Midlands, which he completed in 2007 to become a Consultant Dermatologist. In 2015, he became a Fellow of the Royal College of Physicians (London) as a mark of his medical achievements.
Dr Cheung has held various medical leadership roles within the NHS, which includes the Skin Cancer Lead and clinical Cancer Lead for the hospital, as well as the Dermatology Clinical Director. Furthermore, he has been the regional Dermatology research lead for the West Midlands for the National Institute for Health Research (NIHR), a NHS funded body. In addition, he has been commended for his contribution to clinical research. He has also developed new clinical services such as, dermatology research, photodynamic therapy and an advanced dermatological surgery in some of the hospitals he has worked in.
Further information about his extensive clinical dermatology research experience is found in the "Additional information" section. He has also received a prestigious research award from the NIHR.
Dr Cheung has a broad range of dermatology interests enhanced by considerable experience in various medical leadership roles. He provides a holistic and realistic assessment of your skin issues.
Areas of interest
General Dermatology; Diagnosis and treatment of Skin Cancer; Use of Botox for excess sweating; Hair and nails conditions; Diagnosis and management of acne, eczema; psoriasis, skin allergy, urticaria, and other common skin conditions; Mole checks; Moles and skin lesions removal such as cysts, warts and skin tags
Dr Cheung has been extensively involved in dermatology clinical research, which included studies of new psoriasis, actinic keratosis and vitiligo treatments.
In 2016, he was awarded the prestigious National Institute for Health Research (NIHR) Leading Commercial Principal Investigator Award. He also received earlier commendation from the same awarding Body. Furthermore, he has been the Dermatology co-lead of the NIHR West Midlands Local Clinical Research Network and was a member of the Dermatology National Specialty Group research committee. He remains part of the expert group assessing new studies.
2016 National Institute for Health Research (NIHR) Leading Commercial Principal Investigator
2014 Certificate of Recognition from NIHR for excellent team leader and mentor &
consistently delivery time to target for Commercial studies
His continued academic interest have led him to be involved in the publications of national audits of skin cancer and acne management as well as a dermatology representative of the NICE group that recently produced guidance into certain joint disease care. Furthermore, he is a member of a British Association of Dermatologists subcommittee and involved in producing national guidelines for certain skin conditions.
National audit on the management of bullous pemphigoid. Clin Exp Dermatol. 2019 Sep 10. doi: 10.1111/ced.14086. Smith H, Mohd Mustapa MF, Cheung ST, de Berker DAR
Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma. Cochrane Database Syst Rev. 2019.
Dinnes J, Ferrante di Ruffano L, Takwoingi Y, Cheung ST, Nathan P, Matin RN, Chuchu N, Chan SA, Durack A, Bayliss SE, Gulati A, Patel L, Davenport C, Godfrey K, Subesinghe M, Traill Z, Deeks JJ, Williams HC; Cochrane Skin Cancer Diagnostic Test Accuracy Group.
Tests to assist in the staging of cutaneous melanoma: a generic protocol.
Cochrane Database of Systemic Reviews 2017, issue 9
Dinnes J, Saleh D, Newton-Bishop J, Cheung S, Nathan P, Matin RN, Chuchu N, Bayliss SE, Takwoingi Y, Davenport C, Godfrey K, O'Sullivan C, Deeks JJ, Williams HC.
Compliance with isotretinoin national guidelines – where are we 2 years since the last audit? The results of the national isotretinoin re-audit 2014. L. Exton, S. T. Cheung, D. A. R. de Berker, A. Brain and M. F. Mohd Mustapa. Clin Exp Derm 2017; 381-9
British Association of Dermatologists’ national audit on nonmelanoma skin cancer excision, 2014. (pubiished 2016) D. J. Keith, D. A. R. de Berker, A. P. Bray, S. T. Cheung, A. Brain and M. F. Mohd Mustapa. Clin Exp Derm 2016; 46-53
- MB ChB Dundee Medical School 2000
- MRCP Royal College of Physicians (London) 2003
- CCT (Dermatology) Joint Royal Colleges of Physicians’ Training Board 2007
- FRCP Royal College of Physicians (London) 2015
Reference number 4730161
Details of entry to specialist register
- Dermatology, 2007
Affiliations / memberships
Fellow of the Royal College of Physicians
A member of the following societies:
British Association of Dermatologists
British Society of Dermatological Surgery
British Medical Dermatology Society
British Hair and Nail Society
British Society for Cutaneous Allergy
European Academy of Dermatology and Venereology
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details